Literature DB >> 7047117

Diabetic management in patients with renal failure.

J A Amico, I Klein.   

Abstract

The management of diabetes in patients with renal disease requires understanding of the multiple changes in carbohydrate metabolism that accompany renal failure. A decrease in insulin requirements may occur due to changes in insulin clearance or insulin metabolism. With the onset of uremia, a peripheral resistance to insulin action develops that often requires increased insulin administration, and this resistance can be expected to improve with adequate dialysis. Hypoglycemia may occur as a result of decreased gluconeogenesis, excessive insulin action, or decreased caloric intake. Thus, the treatment of diabetes in the settings of renal failures involves anticipation of changes in insulin sensitivity and insulin dosages. An overall management plan that coordinates diet, insulin, and dialysis where appropriate is most likely to yield optimum diabetic care.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7047117     DOI: 10.2337/diacare.4.3.430

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  9 in total

1.  Continuous subcutaneous insulin infusion (CSII) in insulin-dependent diabetes.

Authors:  M Varghese; K Walshe; P M Bell; D R Hadden; A L Kennedy; J A Weaver
Journal:  Ir J Med Sci       Date:  1983-02       Impact factor: 1.568

Review 2.  Metabolic memory and diabetic nephropathy: potential role for epigenetic mechanisms.

Authors:  Stephen Tonna; Assam El-Osta; Mark E Cooper; Chris Tikellis
Journal:  Nat Rev Nephrol       Date:  2010-04-27       Impact factor: 28.314

3.  Glycaemic control in diabetic nephropathy.

Authors:  J J Bending; J C Pickup; G C Viberti; H Keen
Journal:  Br Med J (Clin Res Ed)       Date:  1984-04-21

4.  Day-to-day variation of insulin requirements of patients with type 2 diabetes and end-stage renal disease undergoing maintenance hemodialysis.

Authors:  Eugene Sobngwi; Sostanie Enoru; Gloria Ashuntantang; Marcel Azabji-Kenfack; Mesmin Dehayem; Arnold Onana; Daniel Biwole; François Kaze; Jean-François Gautier; Jean-Claude Mbanya
Journal:  Diabetes Care       Date:  2010-03-09       Impact factor: 17.152

5.  Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus.

Authors:  C Meyer; M Stumvoll; V Nadkarni; J Dostou; A Mitrakou; J Gerich
Journal:  J Clin Invest       Date:  1998-08-01       Impact factor: 14.808

Review 6.  Interactions between kidney disease and diabetes: dangerous liaisons.

Authors:  Roberto Pecoits-Filho; Hugo Abensur; Carolina C R Betônico; Alisson Diego Machado; Erika B Parente; Márcia Queiroz; João Eduardo Nunes Salles; Silvia Titan; Sergio Vencio
Journal:  Diabetol Metab Syndr       Date:  2016-07-28       Impact factor: 3.320

Review 7.  MicroRNA in diabetic nephropathy: renin angiotensin, aGE/RAGE, and oxidative stress pathway.

Authors:  Shinji Hagiwara; Aaron McClelland; Phillip Kantharidis
Journal:  J Diabetes Res       Date:  2013-12-15       Impact factor: 4.011

8.  Effectiveness of Dose Adjustment of Insulin in Type 2 Diabetes among Hemodialysis Patients with End-Stage Renal Disease: A Randomized Crossover Study.

Authors:  Amol Singhsakul; Ouppatham Supasyndh; Bancha Satirapoj
Journal:  J Diabetes Res       Date:  2019-11-13       Impact factor: 4.011

Review 9.  Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials.

Authors:  Nigel A Calcutt; Mark E Cooper; Tim S Kern; Ann Marie Schmidt
Journal:  Nat Rev Drug Discov       Date:  2009-05       Impact factor: 84.694

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.